Texas Oncology - Northeast — Tyler, Texas

Texas Oncology - Northeast is a clinical research site located in Tyler, Texas, United States 75702.

Crixeo Clinical Trials Trust Score: 27/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology - Northeast has participated in 57 clinical trials with 41 currently active.

Therapeutic areas: Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC), Peripheral T-cell Lymphoma, HER2-Positive Early Breast Cancer.

Sponsors: Stingray Therapeutics, Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tyler

Browse all research sites in Texas · View every site in Tyler

• University of Texas Health Center at Tyler - Titus Regional Hospital
• Mother Frances Hospital
• The University of Texas Health Science Center at Tyler/HOPE Cancer Center
• The University of Texas Health Science at Tyler
• Trinity Mother Frances Hospitals and Clinics
• The University of Texas Health Science Center at Tyler on behalf of UT Health East Texas HOPE Cancer
• The University of Texas Health Science Center at Tyler - Pulmonology
• The University of Texas Health Science Center at Tyler Center for Clinical Research
• The University of Texas Health Science Center
• Christus Mother Frances Hospital
• Christus Health Frances Hospital
• The University of Texas Health Center at Tyler

Sponsor Feasibility Report

Trust Score: 27/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - Northeast?

Texas Oncology - Northeast has a Crixeo Trust Score of 27/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - Northeast conducted?

Texas Oncology - Northeast has 57 clinical trials on record, with 41 currently active. Their work covers Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC), Peripheral T-cell Lymphoma, HER2-Positive Early Breast Cancer.

Is Texas Oncology - Northeast accredited by Crixeo Clinical Trials?

Texas Oncology - Northeast has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology - Northeast?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.